Your browser doesn't support javascript.
loading
Cardiovascular Safety of Tocilizumab Versus Tumor Necrosis Factor Inhibitors in Patients With Rheumatoid Arthritis: A Multi-Database Cohort Study.
Kim, Seoyoung C; Solomon, Daniel H; Rogers, James R; Gale, Sara; Klearman, Micki; Sarsour, Khaled; Schneeweiss, Sebastian.
Afiliación
  • Kim SC; Brigham and Women's Hospital, Boston, Massachusetts.
  • Solomon DH; Brigham and Women's Hospital, Boston, Massachusetts.
  • Rogers JR; Brigham and Women's Hospital, Boston, Massachusetts.
  • Gale S; Genentech, South San Francisco, California.
  • Klearman M; Genentech, South San Francisco, California.
  • Sarsour K; Genentech, South San Francisco, California.
  • Schneeweiss S; Brigham and Women's Hospital, Boston, Massachusetts.
Arthritis Rheumatol ; 69(6): 1154-1164, 2017 06.
Article en En | MEDLINE | ID: mdl-28245350

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Enfermedades Cardiovasculares / Factor de Necrosis Tumoral alfa / Antirreumáticos / Anticuerpos Monoclonales Humanizados Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Arthritis Rheumatol Año: 2017 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Enfermedades Cardiovasculares / Factor de Necrosis Tumoral alfa / Antirreumáticos / Anticuerpos Monoclonales Humanizados Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Arthritis Rheumatol Año: 2017 Tipo del documento: Article